Karbicombi

Hydrochlorothiazide, the active ingredient in Karbicombi, is a thiazide diuretic presented as a combination tablet for oral use. It works together with candesartan cilexetil, an angiotensin II receptor blocker, to lower elevated blood pressure in adults with hypertension. The fixed‑dose formulation targets both fluid volume and vascular tone, offering complementary mechanisms that improve blood pressure control.

GNH USA supplies Karbicombi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Karbicombi, a fixed‑dose antihypertensive combination, is used to manage high blood pressure. - Hypertension: lowers systolic and diastolic blood pressure in adults with essential hypertension. - Cardiovascular risk reduction: contributes to decreased risk of stroke and heart attack by maintaining target blood pressure. - Treatment simplification: replaces separate prescriptions of a thiazide diuretic and an ARB, improving adherence.

Karbicombi may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: light‑headedness, especially after the first doses. - Headache: mild to moderate intensity. - Increased urination: due to the diuretic component. - Electrolyte disturbances: such as low potassium or sodium. - Fatigue: general feeling of tiredness. - Cough: occasional dry cough.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Hyperkalemia or hypokalemia: dangerous potassium level changes. - Acute kidney injury: sudden decline in renal function. - Angioedema: swelling of face, lips, tongue or throat. - Severe hypotension: dangerously low blood pressure.

Before prescribing Karbicombi, clinicians should consider several precautionary measures to ensure safe use. - Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine clearance before and during therapy. - Use caution in the elderly: increased sensitivity to blood pressure changes. - Avoid concurrent use with potassium‑sparing diuretics: risk of hyperkalemia. - Review NSAID use: may diminish diuretic efficacy and affect renal function. - Store at room temperature: keep in the original container, protect from moisture and light.

Karbicombi can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): combined use may increase risk of renal impairment. - Lithium: diuretic may raise lithium levels, leading to toxicity. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely): - Other antihypertensives: additive blood pressure lowering may require dose adjustment. - NSAIDs: can reduce diuretic effect and impair renal function.